Answers are grounded in this paper and cite their sources.
Analysis shows recurrence in cancer survivors is significant, indicating new challenges for treatment strategies.
In 2025, more than 2 million new cases of cancer are expected to be diagnosed in the United States, with the number of cancer survivors expected to increase from approximately 18 million in 2020 to 26 million by 2040. [1][2] But of course, being a cancer survivor doesn’t end the cancer story. As many as 20-40% of patients treated with surgery for one of the four most common solid tumor cancers—breast, colorectal, lung, and prostate—experience recurrence.
No takes yet. Share an insight, caveat, or question.
Yuri Fesko (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: